Scleroderma is an autoimmune connective tissue and rheumatic disease that is caused by the immune system attacking the connective tissue under the skin and around internal organs and blood vessels, which can lead to scarring and thickening of the tissue in these areas. It’s a progress disease that can produce symptoms and complications varying widely in people with scleroderma and ranging from mild to severe.
About Our Program
The Michigan Medicine Scleroderma Program, established in 2004 in the Division of Rheumatology, is a multidisciplinary group of researchers and health care providers dedicated to advancing research and improving care for patients with scleroderma and its related complications. Our team consists of specialists from many disciplines, including rheumatology, pulmonary, cardiology, gastroenterology, infectious diseases, dermatology, physical medicine & rehabilitation, and plastic surgery.